New choices for patients: Transfusion-free medicine for Jehovah's Witnesses and transfusion-wary

December 05, 2007

PHILADELPHIA--"Jehovah's Witness patients no longer have to die for want of blood," says Patricia Ford, MD, a hematologist/oncologist and Medical Director of the Center for Bloodless Medicine and Surgery at Pennsylvania Hospital, part of the PENN Medicine hospital network. Dr. Ford is one of the pioneers of bloodless surgery and has been teaching its technique to doctor's around the world.

One technique a bloodless surgery can employ is called "cell salvage" in which blood lost during surgery is siphoned from the body, passed through a filter for cleaning and returned to the body. It can also be used by the physician during surgery to limit blood loss and to avoid the need for transfusion of blood from sources other than the patient.

Jehovah's Witness patients believe that accepting blood from a source other then themselves defies the scriptural teachings that their religion holds steadfast. Originally developed to meet the needs of the Jehovah's Witness community, bloodless surgery is transfusion-free and is acceptable to Jehovah Witness followers because they are being reinfused with their own blood. Bloodless surgery and medicine is a viable and life-saving option for these patients and those wary of the safety of the blood supply, and it is safe for a growing number of surgical and medical conditions, except for acute leukemia and traumatic injury.

"Bloodless procedures have proven to be safer than blood transfusion because they help eliminate complications resulting from transfusions such as immunosuppression, infection, diseases from emerging pathogens for which our blood supply is not yet tested," said Dr. Ford. "The hospital stay is also shorter for our bloodless patients, a cost savings for the patient and the institution," she continues. Pennsylvania Hospital in Philadelphia is one of the pioneering centers for bloodless medicine and surgery.

Dr. Ford likens the weeks-old blood often used for transfusions to "water from a dirty fish tank." Depleted of most of its oxygen-carrying capacity, the stored blood is not maximally beneficial to any patient.

Prior to surgery, Dr. Ford prepares patients carefully - using medicines to build red blood cells, and managing their hemoglobin count. A higher hemoglobin level lowers the risk of transfusion.

Dr. Ford has performed the largest number of successful stem cell transplants without blood transfusion of anyone in the world. Among the procedures for which Dr. Ford has prepared patients for bloodless medicine and surgery are cardiothoracic surgery; radical hysterectomies, prostatectomies, cystectomies, and repair of aneurysms, chemotherapy management, and total hip and knee surgery.

The bloodless team at Pennsylvania Hospital has saved the lives of many Jehovah's Witness patients who otherwise would not have received care. "We see patients from all over the country who come to us for our expertise in bloodless medicine. The needs of the Jehovah's Witness community have helped us develop practices that can not only save their lives, but can also benefit the entire patient community," explained Dr. Ford.
-end-
Editor's Note: A Jehovah's Witness patient who received successful bloodless (transfusion-free) total hip replacement surgery at Pennsylvania Hospital Center for Bloodless Medicine and Surgery is available for comment.

To speak to this patient, please contact Lee-Ann Landis at 215-829-8043 or 267-236-2866.

Editor's Note: To speak to Dr. Ford or learn more about Pennsylvania Hospital's Center for Bloodless Medicine and Surgery, please contact Lee-Ann Landis at 215-829-8043 or 267-236-2866.

About Pennsylvania Hospital

Pennsylvania Hospital -- the nation's first -- was founded in 1751 by Benjamin Franklin and Dr. Thomas Bond. Today, the 515-bed acute care facility offers a full-range of diagnostic and therapeutic medical services and is a major teaching and clinical research institution. The hospital has over 25,000 admissions each year, including over 5,000 births. With a national reputation in areas such as orthopaedics, cardiac care, vascular surgery, neurosurgery, otorhinolaryngology (ENT) and urology as well as obstetrics, high-risk maternal and fetal services, neonatology, and behavioral health, the campus also includes specialty treatment centers such as the Joan Karnell Cancer Center, the Center for Bloodless Medicine and Surgery, the PENN Neurological Institute and the radiosurgical Gamma Knife Center. Pennsylvania Hospital is part of the University of Pennsylvania Health System and is located in the historic Society Hill district of Philadelphia.

University of Pennsylvania School of Medicine

Related Blood Transfusion Articles from Brightsurf:

Trial clarifies use of blood transfusion in anaemic heart attack patients
Restricting blood transfusion in anaemic heart attack patients to those with very low haemoglobin levels saves blood with no negative impact on clinical outcomes.

Transient increase in blood pressure promotes some blood vessel growth
Blood vessels are the body's transportation system, carrying oxygen and nutrients to cells and whisking away waste.

How high levels of blood fat cause inflammation and damage kidneys and blood vessels
Viral and bacterial infections are not the only causes of inflammation of body tissue.

Women with anemia twice as likely to need transfusion after cesarean delivery
Pregnant women with anemia are twice as likely to need blood transfusions after a cesarean delivery, as those without the condition, according to a study being presented at the ANESTHESIOLOGY® 2019 annual meeting.

Are blood donor sex, pregnancy history and death of transfusion recipients associated?
Whether blood donors' sex and pregnancy history were associated with death for red blood cell transfusion recipients was investigated in this study that analyzed data from three study groups totaling more than 1 million transfusion recipients.

Red blood cell donor pregnancy history not tied to mortality after transfusion
A new study has found that the sex or pregnancy history of red blood cell donors does not influence the risk of death among patients who receive their blood.

Blood transfusion during liver cancer surgery linked with higher risk of cancer recurrence and death
Receiving a blood transfusion during curative surgery for the most common type of liver cancer (hepatocellular carcinoma) is associated with a much higher risk of cancer recurrence and dying prematurely, according to new research being presented at this year's Euroanaesthesia congress.

Impeding white blood cells in antiphospholipid syndrome reduced blood clots
A new study examined APS at the cellular level and found that two drugs reduced development of blood clots in mice affected with the condition.

Study: Denosumab effective in treating osteoporosis in transfusion dependent thalassemia
For patients with osteoporosis caused by transfusion-dependent thalassemia (TDT), a twice-yearly injection appears to improve spinal bone mineral density, according to a new study.

World's largest transfusion study in cardiac surgery changes transfusion practices
Lower thresholds for blood transfusions for cardiac surgery patients compared to traditional thresholds provide positive patient outcomes and safety at six months after surgery, according to the world's largest research study on this topic.

Read More: Blood Transfusion News and Blood Transfusion Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.